Researchers have identified a b-cell marker called fcrl5 that may have diagnostic and prognostic value for multiple sclerosis. This marker is reported to have novel applications in this area. The discovery of fcrl5's potential role in multiple sclerosis may lead to new approaches in diagnosis and prognosis.